Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInvestment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Abivax (ABVX) Other Operating Expenses: 2024-2025

  • Abivax's Other Operating Expenses rose 64.68% to -$953,110 in Q2 2025 from the same period last year, while for Jun 2025 it was -$7.1 million, marking a year-over-year change of. This contributed to the annual value of $6.4 million for FY2024, which is 8.03% down from last year.
  • According to the latest figures from Q2 2025, Abivax's Other Operating Expenses is -$953,110, which was up 14.03% from -$1.1 million recorded in Q1 2025.
  • Over the past 5 years, Abivax's Other Operating Expenses peaked at -$953,110 during Q2 2025, and registered a low of -$2.7 million during Q2 2024.
  • In the last 2 years, Abivax's Other Operating Expenses had a median value of -$1.7 million in 2024 and averaged -$1.8 million.
  • Data for Abivax's Other Operating Expenses shows a peak YoY skyrocketed of 64.68% (in 2025) over the last 5 years.
  • Over the past 2 years, Abivax's Other Operating Expenses (Quarterly) stood at -$2.7 million in 2024, then spiked by 64.68% to -$953,110 in 2025.
  • Its last three reported values are -$953,110 in Q2 2025, -$1.1 million for Q1 2025, and -$2.7 million during Q2 2024.